Agopyan Nadia 4
4 · Marker Therapeutics, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Agopyan Nadia
VP, Regulatory Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-10+40,000→ 40,000 totalExercise: $3.29Exp: 2031-02-10→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 10, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.